Uneingeschränkter Zugang

Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study


Zitieren

A qualitative study exploring clinician and patient perspectives on the benefits and risks of emerging haemophilia treatments found a broad range of influences on patient choice, with clinicians playing a key role in framing discussions
A qualitative study exploring clinician and patient perspectives on the benefits and risks of emerging haemophilia treatments found a broad range of influences on patient choice, with clinicians playing a key role in framing discussions

Figure 1:

The unique nature of haemophilia in risk-benefit discussions
The unique nature of haemophilia in risk-benefit discussions

Study methodology and participation

PARTICIPANT ID METHODOLOGY
Consultant Haematologist 1 Focus groups
Consultant Haematologist 2
Advanced Nurse Practitioner 1
Advanced Nurse Practitioner 2
Advanced Nurse Practitioner 3
Patient 1
Patient 2
Patient 3
Patient 5
Patient 6
Consultant Haematologist 3 1:1 qualitative interviews
Consultant Haematologist 4
Consultant Haematologist 5
Consultant Haematologist 6
Consultant Haematologist 7
Patient 4
Patient 7

Summary of thematic codes

PARTICIPANT GROUP CONSULTANT HAEMATOLOGISTS (N=7) ADVANCED NURSE PRACTITIONERS (N=3) PATIENTS (N=7)
Minor themes (n) 50 18 30
Major themes (n) 13 8 11
Major themes (list)

Bias

Clinician influence

Clinician risk-training

Clinician gateway for the NHS

Cost containment

Gene therapy

Importance of MDT

Media influence

Nature of haemophilia as a disease

Patient communication

Risk

Structure of consultations

Uncertainty

Benefit-risk

Bias

Gene therapy

Inequity of focus

Importance of MDT

Timing of consultation

Training

Treatment choices

Active vs. passive patients

Consultation structure

Evidence sources for new treatments

Experience with current treatment and care

Gateway for the NHS

Gene therapy

Geographical differences in care

Health literacy

Impact of blood inquiry

Importance of MDT

Treatment choices

SUMMARY THEMES (N=5)

Active vs. passive patients

Health literacy

Gene therapy perspectives

External factors

Scar of blood infection scandal

eISSN:
2055-3390
Sprache:
Englisch
Zeitrahmen der Veröffentlichung:
Volume Open
Fachgebiete der Zeitschrift:
Medizin, Vorklinische Medizin, Grundlagenmedizin, andere, Klinische Medizin, Pharmazie, Pharmakologie